Long non-coding RNA expression profiles in peripheral blood mononuclear cells of patients with coronary artery

Wei Zhong1,2,3, Qiaoting Deng2,3,4, Xunwei Deng2,3,4

  • 1Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Hospital Affiliated to Sun Yat-sen University, Meizhou, China.

Insights

Long non-coding RNAs (lncRNAs) show altered expression in peripheral blood mononuclear cells (PBMC) of coronary artery disease (CAD) patients. These lncRNAs may serve as potential biomarkers for early detection of cardiac abnormalities.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cardiovascular Research

Background:

  • Coronary artery disease (CAD) is a major cause of mortality and a complex systemic condition.
  • Investigating gene expression in peripheral blood mononuclear cells (PBMC) offers insights into systemic disease processes.

Purpose of the Study:

  • To determine the expression profiles of long non-coding RNAs (lncRNAs) in PBMCs from CAD patients.
  • To identify potential lncRNA biomarkers for subclinical cardiac abnormalities.

Main Methods:

  • lncRNA expression profiling using Illumina Hiseq 4000 sequencer on PBMCs from 40 CAD patients and 10 controls.
  • Validation of differentially expressed lncRNAs via quantitative real-time polymerase chain reaction (qRT-PCR).
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses for functional prediction.

Main Results:

  • Significant differential expression of lncRNAs observed: 83 upregulated and 114 downregulated (P<0.05).
  • Expression profiles of 48 lncRNAs correlated with CAD severity.
  • GO analysis linked dysregulated lncRNAs to chromatin organization and protein heterodimerization; pathway analysis implicated viral carcinogenesis and autoimmune diseases.

Conclusions:

  • lncRNAs in PBMCs represent potential biomarkers for subclinical cardiac abnormalities in CAD.
  • Further research is necessary to validate these preliminary findings and their clinical utility.
Abstract

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
359
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
207
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
685
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
181